Diabecline
NDC 43074-112
Product Information
Diabecline is a OTC MONOGRAPH FINAL-approved product labeled by Phillips Company. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 43074-112 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 43074-112?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TETRACYCLINE HYDROCHLORIDE (UNII: P6R62377KV)
- TETRACYCLINE (UNII: F8VB5M810T) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ASCORBIC ACID (UNII: PQ6CK8PD0R)
- CHLORHEXIDINE GLUCONATE (UNII: MOR84MUD8E)
- CHOLECALCIFEROL (UNII: 1C6V77QF41)
- DIMETHYL SULFOXIDE (UNII: YOW8V9698H)
- DIPROPYLENE GLYCOL (UNII: E107L85C40)
- GLUCONOLACTONE (UNII: WQ29KQ9POT)
- GLYCERIN (UNII: PDC6A3C0OX)
- HYDROXYMETHYL CELLULOSE (UNII: 273FM27VK1)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SORBIC ACID (UNII: X045WJ989B)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1542813 - tetracycline HCl 3 % Topical Ointment
- RxCUI: 1542813 - tetracycline hydrochloride 0.03 MG/MG Topical Ointment
- RxCUI: 1542815 - Diabecline 3 % Topical Ointment
- RxCUI: 1542815 - tetracycline hydrochloride 0.03 MG/MG Topical Ointment [Diabecline]
- RxCUI: 1542815 - Diabecline 0.03 MG/MG Topical Ointment
* Please review the full disclaimer at the bottom of this page.